doi: 10.1503/cmaj.050575.
Patent nonsense: evidence tells of an industry out of social control
Affiliations
- PMID: 16908900
- PMCID: PMC1534100
- DOI: 10.1503/cmaj.050575
Item in Clipboard
Patent nonsense: evidence tells of an industry out of social control
CMAJ.
.
No abstract available
Figures
Fig. 1: Framework representing chain of operations of pharmaceutical companies.
Comment in
-
Industrial health research in Canada.CMAJ. 2007 Jun 5;176(12):1734; author reply 1734. doi: 10.1503/cmaj.1060190. CMAJ. 2007. PMID: 17548390 Free PMC article. No abstract available.
Similar articles
-
The effect of drug reimportation on managed care pharmacy.Manag Care Interface. 2003 Jul;16(7):41-2. Manag Care Interface. 2003. PMID: 12908216 No abstract available.
-
[European drug policy: welcomed modernization but shortage of political proposals concerning industry and research].Lakartidningen. 2003 Oct 30;100(44):3541-2. Lakartidningen. 2003. PMID: 14651017 Swedish. No abstract available.
-
The new drug war.Fortune. 2004 Mar 8;149(5):144-6, 148, 150 passim. Fortune. 2004. PMID: 15015428 No abstract available.
-
The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.Nurs Econ. 2005 Nov-Dec;23(6):307-11, 279. Nurs Econ. 2005. PMID: 16459902 Review.
-
The North American Free Trade Agreement's effect on pharmaceutical patents: a bitter pill to swallow or a therapeutic solution?J Contemp Health Law Policy. 1996 Spring;12(2):607-36. J Contemp Health Law Policy. 1996. PMID: 8666736 Review. No abstract available.
Cited by
-
Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.Milbank Q. 2007 Sep;85(3):469-98. doi: 10.1111/j.1468-0009.2007.00496.x. Milbank Q. 2007. PMID: 17718665 Free PMC article.
-
Distributed Drug Discovery, Part 1: linking academia and combinatorial chemistry to find drug leads for developing world diseases.J Comb Chem. 2009 Jan-Feb;11(1):3-13. doi: 10.1021/cc800183m. J Comb Chem. 2009. PMID: 19105724 Free PMC article. No abstract available.
-
Patients not patents: Drug research and development as a public enterprise.Eur J Clin Invest. 2018 Feb;48(2):e12875. doi: 10.1111/eci.12875. Epub 2018 Jan 5. Eur J Clin Invest. 2018. PMID: 29243246 Free PMC article. No abstract available.
-
Reorganising our heads for the care of our health.BMJ Lead. 2024 Dec 23;8(4):352-353. doi: 10.1136/leader-2023-000912. BMJ Lead. 2024. PMID: 38408841 Free PMC article. No abstract available.
-
Competition in pharmaceuticals: more product- than price-oriented?Eur J Health Econ. 2018 Jan;19(1):1-4. doi: 10.1007/s10198-017-0932-4. Eur J Health Econ. 2018. PMID: 28993950 No abstract available.
References
-
- McLean B, Llewellyn M. A bitter pill. Fortune 2001;144:118-22,126,130-2. - PubMed
-
- Becker E. Drug industry seeks to sway prices overseas. New York Times 2003 Nov 27.
-
- Becker E. Trade deal opens Australia to U.S. manufactured goods. New York Times 2004 May 19.
-
- Drahos P, Lokuge B, Faunce T, et al. Pharmaceuticals, intellectual property and free trade: the case of the US–Australia Free Trade Agreement. Prometheus 2004;22:243-57.
-
- Meyerson H. CAFTA's profit motive. Washington Post 2005 Mar 30.
MeSH terms
LinkOut - more resources
Full Text Sources
